The 9-valent HPV vaccine (Gardasil-9; manufactured by Merck) has taken the place of the quadrivalent HPV vaccine (Gardasil) in the U.S. HPV-9 is available in 0.5 mL single-dose vials in packs of 10, according to Merck.
On or before Oct. 31, Gardasil will no longer be available for purchase directly from the company, according to a Merck spokesperson. Wholesalers and physician distributors may have inventory remaining, which may continue to be purchased until their supply is depleted. Merck will continue to manufacture Gardasil for use in markets outside the U.S.
The Vaccines for Children program already has transitioned to the 9-valent HPV vaccine.
The 2016 Immunization Schedule recommends three doses of HPV vaccine for 11- to 12-year-old boys and girls.
The Academy offers an FAQ page for more information on 9-valent HPV vaccine, https://www.aap.org/en-us/Documents/hpv_9_valent_faq.pdf. Direct product-specific questions to Merck at 877-829-6372 or visit www.merckvaccines.com.
